Nexthera Capital’s Insmed INSM Stock Holding History

Nexthera Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$12.1M	Buy	470,741 +186,478	+66%	+$5.19M	10.04%	2
2019 Q1	$8.26M	Sell	284,263 -554,683	-66%	-$14.4M	10.03%	3
2018 Q4	$11M	Buy	838,946 +374,787	+81%	+$5.98M	4.54%	9
2018 Q3	$9.38M	Sell	464,159 -182,704	-28%	-$4.13M	1.8%	19
2018 Q2	$15.3M	Sell	646,863 -271,660	-30%	-$6.99M	2.37%	14
2018 Q1	$20.7M	Buy	918,523 +419,602	+84%	+$11M	3.41%	6
2017 Q4	$15.6M	Buy	498,921 +354,921	+246%	+$10.5M	2.87%	10
2017 Q3	$4.49M	Sell	144,000 -16,000	-10%	-$305K	1.16%	25
2017 Q2	$2.75M	Buy	+160,000	New	+$2.73M	1.2%	22
2017 Q1	–	Sell	-322,044	Closed	-$4.26M	–	43
2016 Q4	$4.26M	Hold	322,044	–	–	2.5%	15
2016 Q3	$4.68M	Buy	322,044 +153,344	+91%	+$1.92M	2.87%	8
2016 Q2	$1.66M	Buy	168,700 +128,700	+322%	+$1.5M	1.44%	16
2016 Q1	$507K	Buy	+40,000	New	+$526K	0.53%	26

Other funds holding INSM

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nexthera Capital's INSM Position: Q2 2019 in Review

Nexthera Capital increased its Insmed (INSM) stake by 66% in Q2 2019, buying an estimated $5.19M and bringing the position to 470,741 shares worth $12.1M. The position accounts for 10.04% of the portfolio, ranked #2.

Nexthera Capital first reported a position in INSM in Q1 2016 and has held it in 13 quarters since. The position peaked at $20.7M in Q1 2018. 171 funds tracked by Wall St. Rank hold INSM as of Q2 2019.

Nexthera Capital held 470,741 shares of Insmed worth $12.1M as of Q2 2019.
Nexthera Capital bought 186,478 Insmed shares in Q2 2019, an estimated $5.19M.
Insmed made up 10.04% of Nexthera Capital's portfolio in Q2 2019, its #2 holding.
Nexthera Capital first reported a position in Insmed in Q1 2016 and has held it in 13 quarters since.
Nexthera Capital's Insmed position peaked at $20.7M in Q1 2018.
171 funds tracked by Wall St. Rank held Insmed as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.